Komori
Ushio (6925) · RiskMitigated

Market Price Fluctuation Risk for Securities

First written in FY2016. 15 of 31 entries say "Materialised", first in FY2017-Q1. Latest entry: FY2026.

31entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2018-Q3 – FY20192016: 320162017: 420172018: 220182019: 420192020: 220202021: 420212022: 420222023: 420232024: 220242025: 120252026: 12026
Same theme, other companies
Market Price Risk on Held Financial InstrumentsA theme 362 companies write about · 361 as a headwind · 2 as a tailwind

The whole theme swung hardest in 2019: 56 of 139 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 365 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「During the fiscal year, impairment losses of ¥159 million were recognized on securities, all of them on shares classified as other securities.」

    Impairment losses on securities decreased from ¥966 million in the previous fiscal year to ¥159 million, reducing the loss impact of price fluctuations.
  2. FY2026-H1MitigatedAnnual report

    「Impairment loss on investment securities 500 159」

    Impairment losses on investment securities decreased from ¥500 million in the same period of the previous year to ¥159 million, reducing the loss impact of price fluctuations.
  3. FY2025-H1WorsenedAnnual report

    「Impairment loss on investment securities 26 500」

    Impairment losses on investment securities increased from ¥26 million in the same period of the previous year to ¥500 million, expanding the loss impact of fluctuations in securities prices.
  4. FY2024MitigatedAnnual report

    「During the fiscal year, impairment losses of ¥34 million were recognized on securities, comprising ¥14 million on shares classified as other securities and ¥20 million on bonds classified as other securities.」

    Impairment losses on securities decreased from ¥212 million in the previous fiscal year to ¥34 million. Meanwhile, a gain on the sale of investment securities of ¥7.006 billion was recognized following the sale of cross-shareholdings and other securities.
  5. FY2024-Q2MitigatedAnnual report

    「The main factors behind the increase were higher inventories due to the delayed sales timing of certain optical equipment, higher cash and deposits from external borrowings, and an increase in investment securities resulting from higher unrealized gains on investment securities held.」

    Unrealized gains on investment securities held increased, resulting in a higher balance of investment securities. Meanwhile, an impairment loss on investment securities of ¥26 million was also recognized in the first half, and the impact of price fluctuations remained.
  6. FY2024-Q1MaterialisedAnnual report

    「The main factor behind the increase was an increase in investment securities resulting from higher unrealized gains on investment securities held.」

    While investment securities increased as unrealized gains on investment securities held rose, an impairment loss on investment securities of ¥11 million was also recognized, and the impact of price fluctuations continued to be reflected in financial figures.
  7. FY2023MaterialisedAnnual report

    「During the fiscal year, impairment losses of ¥212 million were recognized on securities, comprising ¥196 million on shares classified as other securities and ¥16 million on bonds classified as other securities.」

    The risk of fluctuations in securities prices materialized as impairment losses totaling ¥212 million on shares and bonds.
  8. FY2023-Q3MaterialisedAnnual report

    「Impairment loss on securities - 96」

    An impairment loss on securities of ¥96 million was recognized as a non-operating expense, and the risk of fluctuations in securities prices materialized as a loss.
  9. FY2023-Q2MaterialisedAnnual report

    「Impairment loss on securities - 90」

    An impairment loss on securities of ¥90 million was recognized as a non-operating expense, and the risk of fluctuations in securities prices materialized as a loss.
  10. FY2023-Q1MaterialisedAnnual report

    「Impairment loss on securities - 69」

    An impairment loss on securities of ¥69 million was recognized as a non-operating expense, and the risk of fluctuations in securities prices materialized as a loss.
  11. FY2022MitigatedAnnual report

    「Impairment loss on investment securities 320 1」

    Impairment losses on investment securities decreased from ¥320 million in the previous fiscal year to ¥1 million, reducing the loss impact of fluctuations in securities prices.
  12. FY2022-Q3MitigatedAnnual report

    「Impairment loss on investment securities 81 1」

    Impairment losses on investment securities decreased from ¥81 million in the same period of the previous year to ¥1 million, reducing the loss impact of the risk of fluctuations in securities prices.
  13. FY2022-Q2MitigatedAnnual report

    「The main factors behind the increase were higher cash and deposits resulting from the collection of receivables, and an increase in investment securities resulting from higher unrealized gains on investment securities held.」

    Unrealized gains on investment securities held increased, while impairment losses on investment securities decreased from ¥82 million in the same period of the previous year to ¥1 million.
  14. FY2022-Q1MitigatedAnnual report

    「The main factors behind the increase were higher cash and deposits resulting from the collection of receivables, and an increase in investment securities resulting from higher unrealized gains on investment securities held. Impairment loss on investment securities 81 16」

    While unrealized gains on investment securities held increased, impairment losses on investment securities decreased from ¥81 million in the same period of the previous year to ¥16 million, reducing the loss impact of price fluctuations.
  15. FY2021MaterialisedAnnual report

    「During the fiscal year, impairment losses of ¥320 million were recognized on securities, all of them on bonds classified as other securities.」

    The risk of fluctuations in securities prices materialized as a ¥320 million impairment loss on bonds classified as other securities.
  16. FY2021-Q3MaterialisedAnnual report

    「Impairment loss on investment securities - 81」

    An impairment loss on investment securities of ¥81 million was recognized for the nine-month period, and the risk of fluctuations in securities prices continued to materialize as a loss.
  17. FY2021-Q2MaterialisedAnnual report

    「Impairment loss on investment securities - 82」

    An impairment loss on investment securities of ¥82 million was recognized as an extraordinary loss in the first half, and the risk of fluctuations in securities prices continued to materialize.
  18. FY2020MaterialisedAnnual report

    「During the fiscal year, impairment losses of ¥86 million were recognized on securities, comprising ¥53 million on shares of affiliated companies and ¥32 million on shares classified as other securities.」

    The risk of fluctuations in securities prices materialized as impairment losses totaling ¥86 million, including ¥53 million on shares of affiliated companies.
  19. FY2020-Q2RestatedAnnual report

    「During the six-month period ended [current second quarter], there were no new business risks and no material changes to the business risks described in the prior fiscal year's annual securities report.」

    No new occurrence or material change in the risk disclosure is considered to have arisen concerning the risk of fluctuations in securities prices.
  20. FY2020-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no newly arising business or other risks, nor any material changes to the business or other risks described in the securities report for the preceding fiscal year.」

    No new occurrence or material change in the risk disclosure is considered to have arisen concerning the risk of fluctuations in securities prices.
  21. FY2019MaterialisedAnnual report

    「The main factor behind the decrease was a reduction in valuation differences on other securities due to the sale of shares and other factors.」

    Valuation differences on securities held decreased from ¥24.247 billion in the previous fiscal year to ¥14.445 billion, reflecting the impact of price fluctuations in net assets.
  22. FY2019-Q3MaterialisedAnnual report

    「The main factors behind the decrease were a decline in accounts receivable as collection progressed, and a decrease in investment securities resulting from lower unrealized gains on investment securities held.」

    Lower unrealized gains on investment securities held were reflected in a decrease in investment securities. In addition, valuation differences on other securities decreased by ¥3.651 billion.
  23. FY2018MaterialisedAnnual report

    「During the fiscal year, impairment losses of ¥181 million were recognized on other securities.」

    The risk of fluctuations in securities prices was reflected in the full-year loss as an ¥181 million impairment loss on other securities.
  24. FY2018-Q3MaterialisedAnnual report

    「Impairment loss on investment securities - 126」

    An impairment loss on investment securities of ¥126 million was recognized for the nine months ended 31 December, and the risk of fluctuations in securities prices materialized as an actual loss.
  25. FY2018-Q2RestatedAnnual report

    「During the six-month period ended the second quarter, there were no new business or other risks, nor any significant changes to the business or other risks described in the securities report for the previous fiscal year.」

    No material changes are considered to have occurred in the risk of fluctuations in securities prices.
  26. FY2018-Q1RestatedAnnual report

    「During the first 3 months of the current fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    No material changes in the risk disclosure are considered to have occurred concerning the risk of fluctuations in securities prices.
  27. FY2017RestatedAnnual report

    「The Group holds securities as financial assets, and their market value may decline depending on conditions in the stock market and elsewhere. The Group is exposed to the risk of fluctuations in the prices of these securities, which could have a material impact on the Group's operating results and financial condition.」

    The potential impact of fluctuations in securities prices on business performance and financial condition remains unchanged in the annual risk disclosure.
  28. FY2017-Q3RestatedAnnual report

    「During the nine-month period ended the third quarter, there were no new business or other risks, nor any significant changes to the business or other risks described in the securities report for the previous fiscal year.」

    No material changes are considered to have occurred in the risk of fluctuations in securities prices.
  29. FY2017-Q2MaterialisedAnnual report

    「Loss on securities held for trading 160」

    A ¥160 million loss on securities held for trading was recorded as a non-operating expense, and the actual impact of securities price fluctuation risk continues to be disclosed.
  30. FY2017-Q1MaterialisedAnnual report

    「Ordinary profit was ¥431 million, down 87.0% year on year, due to the decline in operating profit, the recognition of foreign exchange losses resulting from exchange rate fluctuations, and the recognition of valuation losses on securities held.」

    Valuation losses on securities held were a factor behind the decline in ordinary profit, and a ¥409 million loss on the operation of securities held for trading was also recorded.
  31. FY2016First statedAnnual report

    「The Group holds securities as financial assets, and their market value may decline depending on conditions in the stock market and elsewhere. The Group is exposed to the risk of fluctuations in the prices of these securities, which could have a material impact on the Group's operating results and financial condition.」

    The Group's holdings of securities as financial assets and the potential impact of a decline in market prices are described.
Moved together

"Lighting and Irradiation Light Sources: Technology, Pricing and Demand Volatility Risks" moved the same way as this thread, in the same document, in 16 of its 31 moves.

161414866★123456
  1. ★This thread
  2. 1Lighting and Irradiation Light Sources: Technology, Pricing and Demand Volatility Risks16×
  3. 2Foreign exchange fluctuation risk associated with foreign currency transactions, investments and financing14×
  4. 3Regional, Technology and Price Volatility Risks for Imaging Equipment14×
  5. 4Risk of Supply and Demand Fluctuations in the Semiconductor and Flat-Panel Display Industries8×
  6. 5Expansion from Light Sources to Equipment, Systems and Solutions6×
  7. 6Maintaining and improving profitability in existing businesses6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Ushio's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.